GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation.

Pitcairn Co. cut its holdings in GSK plc (NYSE:GSK – Free Report) by 14.1% during the 3rd quarter, according to its most ...

GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...

GSK PLC GSK shares inched down 0.63% to £13.38 Tuesday, on what proved to be an all-around poor trading session for the stock ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

GSK plc GSK announced that the FDA accepted its biologics license application (BLA) seeking approval for the Blenrep ...

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.

(Alliance News) - GSK PLC said on Monday that the US Food & Drug Administration accepted a biologics license application for its Blenrep combinations for the treatment of relapsed and refractory ...

SVB reports consulting fees from Bayer, AstraZeneca, GSK, and Vifor Pharma; speaking fees from Bayer, AstraZeneca, Pfizer, and Vifor Pharma (all honoraria paid to his institution); and non-financial ...

Shares of GSK plc (NYSE:GSK – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat.com reports. Seven ...